Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

Clinical trial NCT00920972 · RECRUITING

Trial details

NCT number: NCT00920972
Sponsor: Washington University School of Medicine
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metabolic Disorders Hematologic, Immune, or Bone Marrow Disorders Hemoglobinopathies Non-malignant Disorders

Start date: 2001-12-01
Primary completion: 2026-12-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.